|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300076855 |
|
最近更新日期: Date of Last Refreshed on: |
2023-10-23 08:53:28 |
|
注册时间: Date of Registration: |
2023-10-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
妊娠期糖尿病产妇的胎盘微生物特征及其溯源分析研究 |
|
Public title: |
A Study on the Microbial Characteristics and Traceability of the Placenta of Pregnant Women with Gestational Diabetes Mellitus |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
妊娠期糖尿病产妇的胎盘微生物特征及其溯源分析研究 |
|
Scientific title: |
A Study on the Microbial Characteristics and Traceability of the Placenta of Pregnant Women with Gestational Diabetes Mellitus |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
汪银 |
研究负责人: |
汪银 |
|
Applicant: |
Yin Wang |
Study leader: |
Yin Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 551 6216 0038 |
研究负责人电话:
Study leader's |
+86 551 6216 0038 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangyinanhui@hotmail.com |
研究负责人电子邮件: Study leader's E-mail: |
wangyinanhui@hotmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省合肥市益民街15号 |
研究负责人通讯地址: |
安徽省合肥市益民街15号 |
|
Applicant address: |
No.15,The Profit People Street,Hefei,Anhui |
Study leader's address: |
No.15,The Profit People Street,Hefei,Anhui |
|
申请注册联系人邮政编码: Applicant postcode: |
230001 |
研究负责人邮政编码: Study leader's postcode: |
230001 |
|
申请人所在单位: |
安徽医科大学/安徽省妇幼保健院 |
||
|
Applicant's institution: |
Anhui Province Maternity andAnhui Medical University/ Anhui Province Maternity and Child Health Hospital Child Health Hospital |
||
|
研究负责人所在单位: |
安徽医科大学/安徽省妇幼保健院 |
||
|
Affiliation of the Leader: |
Anhui Province Maternity andAnhui Medical University/ Anhui Province Maternity and Child Health Hospital Child Health Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
83230472 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
安徽医科大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Ethics Committee of Anhui Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-03-01 00:00:00 | ||
|
伦理委员会联系人: |
余永强 |
||
|
Contact Name of the ethic committee: |
Yu Yongqiang |
||
|
伦理委员会联系地址: |
安徽省合肥市梅山路 |
||
|
Contact Address of the ethic committee: |
Meishan Road, Hefei, Anhui |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 551 6516 1053 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
安徽医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Anhui Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省合肥市梅山路 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Meishan Road, Hefei, Anhui |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
安徽省妇幼保健院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Anhui Province Maternity and Child Health Hospital |
||||||||||||||||||||||
|
研究疾病: |
妊娠期糖尿病 |
||||||||||||||||||||||
|
Target disease: |
Gestational diabetes |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
明确GDM患者胎盘组织的微生物表达情况,筛查特异性菌群特征及丰度,明确GDM患者胎盘组织的免疫炎症状态,及其与特异性菌群的相关性,明确GDM患者胎盘组织的微生物来源。 |
||||||||||||||||||||||
|
Objectives of Study: |
To clarify the microbial expression of placental tissue of GDM patients, screen the characteristics and abundance of specific flora, clarify the immune inflammation state of placental tissue of GDM patients and its correlation with specific flora, and clarify the microbial source of placental tissue of GDM patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①单胎孕妇;②被纳入GDM 组患者为在妊娠24?28周进行OGTT试验后,采用《中国2型糖尿病防治指南2020年版》推荐诊断标准,明确诊断为GDM。③观察组患者符合剖宫产的指征并接受剖宫产;④患者对本研究内容知情,自愿参加并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
① Single pregnant women;② Patients included in GDM group were diagnosed as GDM after OGTT test at 24 ~ 28 weeks of pregnancy according to the diagnostic criteria recommended by Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition). ③ Patients in observation group met the indications of cesarean section and accepted cesarean section; ④ Patients were informed of the contents of this study, voluntarily participated in and signed the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
①双胎或多胎妊娠;②PGDM、ODM 和其他内分泌疾病(包括甲状腺和肾上腺疾病)的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) twin or multiple pregnancy;(2) PGDM, ODM and other endocrine diseases (including thyroid and adrenal diseases). |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-10-16 00:00:00至 To 2025-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-11-01 00:00:00 至 To 2024-11-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
否 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
No |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
所有临床资料将会录入至具体的CRF表格,由研究人员统一录入和分析,共同管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
All clinical data will be entered into the specific CRF form, which will be entered and analyzed by researchers and managed together. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |